ALZHEIMERS DISEASE RESEARCH FOUNDATION: Form 990, tax year 2023
View the entire original 990 at ProPublica ↗
- Organization
- ALZHEIMERS DISEASE RESEARCH FOUNDATION (EIN 52-2396428)
- Tax period
- 2023-01-01 to 2023-12-31
- Filed
- 2024-05-01
- IRS object ID
- 202421229349300027
- Schema version
- 2023v5.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule L
- Schedule M
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2024-05-01T08:58:07-05:00 | ReturnTs |
| Tax Period End | 2023-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 050409384 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | KAHN LITWIN RENZA & CO LTD | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 951 NORTH MAIN STREET | AddressLine1Txt |
| City | PROVIDENCE | CityNm |
| State Abbreviation | RI | StateAbbreviationCd |
| ZIP | 02904 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2023-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 522396428 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ALZHEIMER'S DISEASE RESEARCH FOUNDATION | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | ALZH | BusinessNameControlTxt |
| Phone | 7812373800 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 34 WASHINGTON ST 310 | AddressLine1Txt |
| City | WELLESLEY HILLS | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02481 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | MARGARET E SMITH | PersonNm |
| Person Title | CEO | PersonTitleTxt |
| Phone | 7812373800 | PhoneNum |
| Signature | 2024-04-30 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | MARGARET | PersonFirstNm |
| Person Last | SMITH | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | 999009999 | SSN |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | Yes (1) | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | SANDY ROSS | PreparerPersonNm |
| PTIN | P01399337 | PTIN |
| Phone | 4012742001 | PhoneNum |
| Preparation | 2024-04-26 | PreparationDt |
Additional Filer Information AdditionalFilerInformation
Trusted Customer TrustedCustomerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trusted Customer | 2 | TrustedCustomerCd |
| Authentication Assurance Level | AAL1 | AuthenticationAssuranceLevelCd |
| Identity Assurance Level | IAL1 | IdentityAssuranceLevelCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2023 | TaxYr |
| Build TS | 2023-04-26 12:10:37Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CURE ALZHEIMER'S FUND | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | MARGARET E SMITH | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 34 WASHINGTON ST 310 | AddressLine1Txt |
| City | WELLESLEY HILLS | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02481 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $46,196,573 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | HTTP://CUREALZ.ORG/ | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2004 | FormationYr |
| Legal Domicile State | PA | LegalDomicileStateCd |
| Activity Or Mission | TO FUND RESEARCH WITH THE HIGHEST PROBABILITY OF PREVENTING, SLOWING OR REVERSING ALZHEIMER'S DISEASE. | ActivityOrMissionDesc |
| Voting Members Governing Body | 7 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 6 | VotingMembersIndependentCnt |
| Total Employee | 36 | TotalEmployeeCnt |
| Total Volunteers | 85 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $32,354,655 | PYContributionsGrantsAmt |
| CY Contributions Grants | $36,697,205 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $8,359,727 | PYInvestmentIncomeAmt |
| CY Investment Income | $1,042,285 | CYInvestmentIncomeAmt |
| PY Other Revenue | -$6,137 | PYOtherRevenueAmt |
| CY Other Revenue | -$14,283 | CYOtherRevenueAmt |
| PY Total Revenue | $40,708,245 | PYTotalRevenueAmt |
| CY Total Revenue | $37,725,207 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $23,431,727 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $26,431,117 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $3,951,303 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $4,878,104 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $1,897,310 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $3,229,984 | PYOtherExpensesAmt |
| CY Other Expenses | $3,324,327 | CYOtherExpensesAmt |
| PY Total Expenses | $30,613,014 | PYTotalExpensesAmt |
| CY Total Expenses | $34,633,548 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $10,095,231 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $3,091,659 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $30,192,784 | TotalAssetsBOYAmt |
| Total Assets EOY | $33,488,279 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $1,734,174 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $1,727,324 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $28,458,610 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $31,760,955 | NetAssetsOrFundBalancesEOYAmt |
| Mission | TO FUND RESEARCH WITH THE HIGHEST PROBABILITY OF PREVENTING, SLOWING OR REVERSING ALZHEIMER'S DISEASE. ALL OVERHEAD EXPENSES ARE PAID BY THE BOARD OF DIRECTORS, TRUSTEES AND CORE GROUP OF SELECT DONORS, ALLOWING 100% OF GENERAL DONATIONS TO FUND OUR RESEARCH PROGRAMS. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $27,793,083 | ExpenseAmt |
| Grant | $26,431,117 | GrantAmt |
| Desc | IN 2023, CURE ALZHEIMER'S FUND SUPPORTED 114 RESEARCH PROJECTS AT 53 LEADING RESEARCH INSTITUTIONS, FOR RESEARCH OUTPUT OF MORE THAN $27.7 MILLION. MANY PROJECTS PURSUED A DEEPER UNDERSTANDING OF THE MECHANISMS OF ACTION OF THE GENES AND VARIANTS WITH THE BIGGEST IMPACT ON RISK AND TIMING OF ALZHEIMER'S DISEASE. OTHER PROJECTS PURSUED NOVEL THEORIES AND TOOLS TO ASSESS POTENTIAL AVENUES FOR PREVENTION AND TREATMENT, IN PARTICULAR REGARDING THE ROLE OF THE GUT MICROBIOME AND IMMUNE SYSTEM IN HEALTHY BRAIN FUNCTION. ADDITIONAL EXPENSES INCLUDE HUSBANDRY OF TRANSGENIC ANIMAL MODELS BY A CONTRACT RESEARCH ORGANIZATION; THE DIRECT SUPPORT OF FACILITATING GRANTS AND THE AWARD PROCESS; AND COSTS ASSOCIATED WITH ASSESSING RESEARCH PROPOSALS AND DETERMINING FUNDING PRIORITIES. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $3,607,458 | ExpenseAmt |
| Desc | CREATING AWARENESS TOOK THE FORM OF MAILINGS, OUTREACH, AND SUPPORT OF THIRD PARTY EVENTS DESIGNED TO RAISE AWARENESS ABOUT THE NEED OF MORE RESEARCH INTO THE ORIGINS AND PROGRESSION OF ALZHEIMER'S DISEASE. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $31,400,541 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (1) | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (1) | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | Yes (1) | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (1) | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | 0 | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 30 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 36 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (1) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (1) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 7 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 6 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (1) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | Yes (1) | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Other Website | Yes (X) | OtherWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MARGARET E SMITH | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 7812373800 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 34 WASHINGTON STREET STE 310 | AddressLine1Txt |
| City | WELLESLEY HILLS | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02481 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (17 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|
| MARGARET SMITH | ||||||||
| CEO (AS OF 10/23) | 40.00 | Yes (X) | Yes (X) | $321,513 | $0 | $28,490 | ||
| HENRY MCCANCE | ||||||||
| CHAIR | 5.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| JACQUELINE MORBY | ||||||||
| DIRECTOR | 5.00 | Yes (X) | $0 | $0 | $0 | |||
| ROBERT GREENHILL | ||||||||
| DIRECTOR | 5.00 | Yes (X) | $0 | $0 | $0 | |||
| RICHARD BIRNBAUM | ||||||||
| DIRECTOR (AS OF 7/23) | 5.00 | Yes (X) | $0 | $0 | $0 | |||
| JEFFREY MORBY | ||||||||
| DIRECTOR (DECEASED 9/23) | 20.00 | Yes (X) | $0 | $0 | $0 | |||
| TIMOTHY ARMOUR | ||||||||
| FORMER PRESIDENT & CEO (TO 09/23) | 40.00 | Yes (X) | Yes (X) | $350,862 | $0 | $10,860 | ||
| LAUREL LYLE | ||||||||
| SECRETARY & VP BOARD RELAT | 30.00 | Yes (X) | Yes (X) | $113,594 | $0 | $3,982 | ||
| PHYLLIS RAPPAPORT | ||||||||
| TREASURER | 2.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| JOSEPHINE ANTONELLIS | ||||||||
| CHIEF FINANCIAL OFFICER (AS OF 8/23) | 30.00 | Yes (X) | $150,986 | $0 | $5,543 | |||
| KATHARINE HERMAN | ||||||||
| EVP DEVELOPMENT | 40.00 | $405,657 | $0 | $30,315 | Yes (X) | |||
| BARBARA CHAMBERS | ||||||||
| EVP MARKETING & COMM. | 40.00 | $254,908 | $0 | $22,740 | Yes (X) | |||
| DANIEL HARPER | ||||||||
| SENIOR PHILANTHROPIC ADVISOR | 40.00 | $181,380 | $0 | $11,960 | Yes (X) | |||
| MAHUA DASGUPTA | ||||||||
| SR. PHILANTROPIC ADVISOR | 40.00 | $168,942 | $0 | $25,164 | Yes (X) | |||
| JOHN SLATTERY | ||||||||
| SVP MAJOR GIFTS | 40.00 | $190,709 | $0 | $6,713 | Yes (X) | |||
| KELLY WESTERHOUSE | ||||||||
| VP LEADERSHIP GIVING | 40.00 | $155,421 | $0 | $10,356 | Yes (X) | |||
| LISA RAND | ||||||||
| VP MARKETING & COMM. | 40.00 | $193,830 | $0 | $18,277 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $2,487,802 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $174,400 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 16 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (3 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| PROPER VILLAINS LLC | |||||
| 855 BOYLSTON STREET 10TH FLOOR | BOSTON | MA | 02116 | CREATIVE AND PRODUCTION SERVICES | $257,856 |
| SPENCER STUART | |||||
| 353 NORTH CLARK STREET SUITE 2400 | CHICAGO | IL | 60654 | RECRUITING CEO SEARCH | $180,566 |
| GRYPHON CONSULTING LLC | |||||
| 21 DEAN ST | BELMONT | MA | 02478 | FINANCIAL & MGT CONSULTANT | $125,651 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 3 | CntrctRcvdGreaterThan100KCnt |
| Fundraising | $199,600 | FundraisingAmt |
| All Other Contributions | $36,497,605 | AllOtherContributionsAmt |
| Noncash Contributions | $8,382,433 | NoncashContributionsAmt |
| Total Contributions | $36,697,205 | TotalContributionsAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $992,260 | TotalRevenueColumnAmt |
| Exclusion | $992,260 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $8,436,908 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $8,386,883 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $50,025 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $50,025 | TotalRevenueColumnAmt |
| Exclusion | $50,025 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $70,200 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $199,600 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $84,483 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$14,283 | TotalRevenueColumnAmt |
| Exclusion | -$14,283 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $37,725,207 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $1,028,002 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $23,118,277 | TotalAmt |
| Program Services | $23,118,277 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,312,840 | TotalAmt |
| Program Services | $3,312,840 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,736,973 | TotalAmt |
| Program Services | $1,010,353 | ProgramServicesAmt |
| Management And General | $355,663 | ManagementAndGeneralAmt |
| Fundraising | $370,957 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,586,851 | TotalAmt |
| Program Services | $1,423,565 | ProgramServicesAmt |
| Management And General | $371,733 | ManagementAndGeneralAmt |
| Fundraising | $791,553 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $68,504 | TotalAmt |
| Program Services | $39,467 | ProgramServicesAmt |
| Management And General | $8,979 | ManagementAndGeneralAmt |
| Fundraising | $20,058 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $182,234 | TotalAmt |
| Program Services | $95,435 | ProgramServicesAmt |
| Management And General | $34,395 | ManagementAndGeneralAmt |
| Fundraising | $52,404 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $303,542 | TotalAmt |
| Program Services | $170,378 | ProgramServicesAmt |
| Management And General | $51,703 | ManagementAndGeneralAmt |
| Fundraising | $81,461 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $69,536 | TotalAmt |
| Program Services | $7,989 | ProgramServicesAmt |
| Management And General | $55,337 | ManagementAndGeneralAmt |
| Fundraising | $6,210 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $105,190 | TotalAmt |
| Management And General | $105,190 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $78,000 | TotalAmt |
| Program Services | $78,000 | ProgramServicesAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $14,857 | TotalAmt |
| Management And General | $14,857 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $560,597 | TotalAmt |
| Program Services | $235,251 | ProgramServicesAmt |
| Management And General | $164,943 | ManagementAndGeneralAmt |
| Fundraising | $160,403 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $727,294 | TotalAmt |
| Program Services | $700,412 | ProgramServicesAmt |
| Fundraising | $26,882 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $192,314 | TotalAmt |
| Program Services | $73,256 | ProgramServicesAmt |
| Management And General | $37,420 | ManagementAndGeneralAmt |
| Fundraising | $81,638 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $77,392 | TotalAmt |
| Program Services | $9,383 | ProgramServicesAmt |
| Management And General | $68,009 | ManagementAndGeneralAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $199,250 | TotalAmt |
| Program Services | $114,272 | ProgramServicesAmt |
| Management And General | $32,882 | ManagementAndGeneralAmt |
| Fundraising | $52,096 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $134,887 | TotalAmt |
| Program Services | $58,136 | ProgramServicesAmt |
| Management And General | $1,540 | ManagementAndGeneralAmt |
| Fundraising | $75,211 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $273,478 | TotalAmt |
| Program Services | $260,906 | ProgramServicesAmt |
| Fundraising | $12,572 | FundraisingAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,042 | TotalAmt |
| Management And General | $3,042 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $26,714 | TotalAmt |
| Program Services | $4,403 | ProgramServicesAmt |
| Management And General | $20,304 | ManagementAndGeneralAmt |
| Fundraising | $2,007 | FundraisingAmt |
Other Expenses OtherExpensesGrp (3 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | FundraisingFundraisingAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|---|
| RESEARCH LAB EXPENSES | $659,485 | $659,485 | ||
| GIFT PROCESSING FEES | $147,164 | $147,164 | ||
| MISCELLANEOUS | $55,127 | $28,733 | $16,694 | $9,700 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $34,633,548 | TotalAmt |
| Program Services | $31,400,541 | ProgramServicesAmt |
| Management And General | $1,335,697 | ManagementAndGeneralAmt |
| Fundraising | $1,897,310 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,778,505 | BOYAmt |
| EOY | $1,219,384 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,254,987 | BOYAmt |
| EOY | $3,993,426 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,877,735 | BOYAmt |
| EOY | $3,783,152 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $218,532 | BOYAmt |
| EOY | $239,429 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $54,458 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $54,458 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,042 | BOYAmt |
| EOY | $0 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $17,733,326 | BOYAmt |
| EOY | $24,112,740 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $326,657 | BOYAmt |
| EOY | $140,148 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $30,192,784 | BOYAmt |
| EOY | $33,488,279 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $129,949 | BOYAmt |
| EOY | $316,299 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $763,585 | BOYAmt |
| EOY | $718,427 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $840,640 | BOYAmt |
| EOY | $692,598 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,734,174 | BOYAmt |
| EOY | $1,727,324 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $26,297,281 | BOYAmt |
| EOY | $27,791,118 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,161,329 | BOYAmt |
| EOY | $3,969,837 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $28,458,610 | BOYAmt |
| EOY | $31,760,955 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $30,192,784 | BOYAmt |
| EOY | $33,488,279 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $3,091,659 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $210,686 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Info In Schedule O Part XII | Yes (X) | InfoInScheduleOPartXIIInd |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $30,497,342 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $22,874,388 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $26,547,838 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $32,354,655 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $36,697,205 | CurrentTaxYearAmt |
| Total | $148,971,428 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $30,497,342 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $22,874,388 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $26,547,838 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $32,354,655 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $36,697,205 | CurrentTaxYearAmt |
| Total | $148,971,428 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $17,584,394 | SubstantialContributorsTotAmt |
| Public Support Total170 | $131,387,034 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $83,306 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $15,472 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $4,497 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $93,408 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $992,260 | CurrentTaxYearAmt |
| Total | $1,188,943 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $150,160,371 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $213,300 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.87500 | PublicSupportCY170Pct |
| Public Support PY170 | 0.88510 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Volunteers | 0 | VolunteersInd |
| Paid Staff Or Management | 0 | PaidStaffOrManagementInd |
| Media Advertisements | 0 | MediaAdvertisementsInd |
| Mailings Members | 0 | MailingsMembersInd |
| Publications Or Broadcast | 0 | PublicationsOrBroadcastInd |
| Grants Other Organizations | 0 | GrantsOtherOrganizationsInd |
| Direct Contact Legislators | Yes (1) | DirectContactLegislatorsInd |
| Direct Contact Legislators | $78,000 | DirectContactLegislatorsAmt |
| Rallies Demonstrations | 0 | RalliesDemonstrationsInd |
| Other Activities | 0 | OtherActivitiesInd |
| Total Lobbying Expenditures | $78,000 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | 0 | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART II-B, LINE 1(G) | FormAndLineReferenceDesc |
| Explanation | A REGISTERED LOBBYIST CONTACTED VARIOUS CONGRESSIONAL LEGISLATORS FOR THE PURPOSE OF ENCOURAGING INCREASED FUNDING OF ALZHEIMER'S DISEASE RESEARCH BY THE FEDERAL GOVERNMENT. | ExplanationTxt |
Schedule D IRS990ScheduleD
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $7,767 | OtherCostOrOtherBasisAmt |
| Depreciation | $7,767 | DepreciationAmt |
| Book Value | $0 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $46,691 | OtherCostOrOtherBasisAmt |
| Depreciation | $46,691 | DepreciationAmt |
| Book Value | $0 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $0 | TotalBookValueLandBuildingsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)
| DescDesc | AmtAmt |
|---|---|
| ACCRUED PAYROLL AND RELATED | $566,892 |
| LEASE PAYABLE | $125,706 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $692,598 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $37,921,036 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $210,686 | NetUnrealizedGainsInvstAmt |
| Revenue Not Reported | $210,686 | RevenueNotReportedAmt |
| Revenue Subtotal | $37,710,350 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $14,857 | InvestmentExpensesNotIncldAmt |
| Revenue Not Reported Fincl Stmt | $14,857 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $37,725,207 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $34,618,691 | TotExpnsEtcAuditedFinclStmtAmt |
| Expenses Not Reported | $0 | ExpensesNotReportedAmt |
| Expenses Subtotal | $34,618,691 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $14,857 | InvestmentExpensesNotIncld2Amt |
| Expenses Not Rpt Fincl Stmt | $14,857 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $34,633,548 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART X, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE ORGANIZATION IS EXEMPT FROM INCOME TAXES AS A PUBLIC CHARITY UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. MANAGEMENT BELIEVES THAT THE ORGANIZATION OPERATES IN A MANNER CONSISTENT WITH ITS TAX-EXEMPT STATUS AT BOTH THE STATE AND FEDERAL LEVELS. THE ORGANIZATION ANNUALLY FILES IRS FORM 990 RETURNS OF ORGANIZATIONS EXEMPT FROM INCOME TAX, REPORTING VARIOUS INFORMATION THAT THE IRS USES TO MONITOR THE ACTIVITIES OF TAX-EXEMPT ENTITIES. THESE TAX RETURNS ARE SUBJECT TO REVIEW BY THE TAXING AUTHORITIES, GENERALLY FOR A PERIOD OF THREE YEARS AFTER THEY WERE FILED. THE ORGANIZATION CURRENTLY HAS NO TAX EXAMINATIONS IN PROGRESS. | ExplanationTxt |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (3 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | 0 | 0 | GRANTS AWARDED | ALZHEIMER'S DISEASE RESEARCH _ 0 | $2,284,252 |
| MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT, | 0 | 0 | GRANTS AWARDED | ALZHEIMER'S DISEASE RESEARCH | $540,155 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | GRANTS AWARDED | ALZHEIMER'S DISEASE RESEARCH | $488,433 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $3,312,840 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $3,312,840 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (18 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt | Non Cash AssistanceNonCashAssistanceAmt |
|---|---|---|---|---|
| BELGIUM | IDENTIFYING MEDIATORS OF TAU MEDIATED NEURONAL NECROPTOSIS USING AN INNOVATIVE IN VIVO CRISPR SCREEN | $230,000 | ACH | $0 |
| FINLAND | NEUROINFLAMMATION AT THE CHOROID PLEXUS IN ALZHEIMER'S DISEASE | $11,500 | ACH | $0 |
| GERMANY | SIGNALING FUNCTION OF TREM2 CLEAVAGE PRODUCTS, WHICH ARE AFFECTED BY AGONISTIC ANTIBODIES TO THE STALK REGION | $172,500 | ACH | $0 |
| GERMANY | CSF NEUROINFLAMMATORY SIGNATURE IN ALZHEIMER'S DISEASE AND RELATED PROTEOPATHIES | $180,550 | ACH | $0 |
| GERMANY | ADDING GENOMICS AND METHYLOMICS TO PERSONALIZED DISEASE PREDICTION FOR ALZHEIMER'S DISEASE (EPIC4AD) | $116,684 | ACH | $0 |
| GERMANY | CHARACTERIZATION OF THE LONGITUDINAL TRAJECTORIES OF THE SYNAPTIC BLOOD MARKER -SYNUCLEIN DURING AD PATHOGENESIS AND IMPROVEMENT OF THE MEASUREMENT PROCEDURE | $144,325 | ACH | $0 |
| HONG KONG | APOE CONSORTIUM: APOE GENOTYPE-SPECIFIC EFFECTS OF HUMAN YOUNG PLASMA ON CEREBROVASCULATURE AND AD PATHOLOGY | $287,500 | ACH | $0 |
| ISRAEL | DECODING MICROBIAL PRODUCTS MODULATING ALZHEIMER'S DISEASE - TOWARDS PRECISION POSTBIOTICS TREATMENT | $201,250 | ACH | $0 |
| ISRAEL | A PROPOSAL TO EVALUATE THE EFFECT OF BCG VACCINATION ON ALZHEIMER'S DISEASE DEVELOPMENT | $223,100 | ACH | $0 |
| ISRAEL | UNDERSTANDING THE MECHANISM UNDERLYING VACCINATION FOR ALZHEIMER'S DISEASE | $115,805 | ACH | $0 |
| ITALY | EXTRACELLULAR ATP IS A KEY FACTOR IN PROMOTING ALZHEIMER'S DISEASE NEUROINFLAMMATION | $150,000 | ACH | $0 |
| NETHERLANDS | DISENTANGLING THE ROLE OF INTRACRANIAL ARTERIOSCLEROSIS IN ALZHEIMER'S DISEASE | $167,207 | ACH | $0 |
| NETHERLANDS | UNDERSTANDING THE DYNAMIC LIPID-IMMUNOMETABOLOME OF PROTECTIVE AND RISK ALZHEIMER MICROGLIA | $201,250 | ACH | $0 |
| NEW ZEALAND | CHARACTERIZATION AND VALIDATION OF TWO RECENTLY CREATED SHEEP MODELS OF ALZHEIMER'S DISEASE IN PREPARATION FOR USE AS A PRECLINICAL PHARMACEUTICAL TESTING MODELS | $200,933 | ACH | $0 |
| SWEDEN | CHARACTERIZATION OF TAU PATHOLOGY HETEROGENEITY ACROSS THE ALZHEIMER'S DISEASE SPECTRUM | $201,250 | ACH | $0 |
| UNITED KINGDOM | INFLUENCE OF PLAQUE VICINITY ON MICROGLIAL AND ASTROCYTE GENE EXPRESSION; ROLE OF HUMAN TAU AND TREM2 | $172,369 | ACH | $0 |
| UNITED KINGDOM | SCALING THE DIVIDE IN ALZHEIMER'S DISEASE: AN INTEGRATED MOLECULAR, CELLULAR AND NETWORK-LEVEL STUDY | $191,624 | ACH | $0 |
| UNITED KINGDOM | ADTC: IMPACT OF TAU MUTATIONS AND A ON TAU POST-TRANSLATIONAL MODIFICATIONS AND CONFORMATION | $344,993 | ACH | $0 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 15 | Total501c3OrgCnt |
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE RESEARCH LEADERSHIP GROUP REVIEWS EACH PROJECT FOR FIT WITH THE CUREALZ RESEARCH PORTFOLIO, SCIENTIFIC INTEGRITY, AND VALUE TO THE SEARCH FOR A CURE FOR ALZHEIMER'S DISEASE. ALL FUNDED RESEARCHERS MAY BE ASKED TO REVIEW OCCASIONAL PROPOSALS ON A TWO-WEEK TIMELINE AS A CONDITION OF RECEIVING FUNDING. THE RESEARCH COMMITTEE OF THE BOARD OF DIRECTORS PROVIDES A FINAL REVIEW TO ENSURE ALL PROCEDURES HAVE BEEN FOLLOWED AND THAT THE PROJECT SERVES THE ORGANIZATION'S MISSION TO FUND RESEARCH ACCELERATING BENEFITS TO CURRENT AND POTENTIAL ALZHEIMER'S PATIENTS. AT LEAST TWO SCIENTIFIC REVIEWERS MUST SUBMIT A POSITIVE REVIEW FOR A PROPOSAL TO BE ACCEPTED. ANY QUESTIONS OR CONCERNS ABOUT THE PROPOSAL BY ANY REVIEWER MAY RESULT IN A REQUEST FOR ITERATION OR REJECTION OF THE PROPOSAL. RESEARCHERS WILL BE ADVISED OF ACCEPTANCE, QUESTIONS, OR REJECTION BUT WILL NOT RECEIVE ANY "SCORE OR ASSESSMENT COMMENTARY FROM REVIEWERS; HOWEVER, SUGGESTIONS OR IDEAS FROM REVIEWERS ARE SYNTHESIZED AND PROVIDED WITHOUT ATTRIBUTION IF A PROPOSAL IS FUNDED. | ExplanationTxt |
Schedule G IRS990ScheduleG
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | FISHER ISLAND GOLF | Event1Nm |
| Gross Receipts Event1 | $269,800 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $199,600 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $70,200 | GrossRevenueEvent1Amt |
| Rent Facility Costs Event1 | $52,000 | RentFacilityCostsEvent1Amt |
| Food And Beverage Event1 | $4,793 | FoodAndBeverageEvent1Amt |
| Other Direct Expenses Event1 | $27,690 | OtherDirectExpensesEvent1Amt |
| Gross Receipts Total | $269,800 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $199,600 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $70,200 | GrossRevenueTotalEventsAmt |
| Rent Fclty Costs Total Events | $52,000 | RentFcltyCostsTotalEventsAmt |
| Food And Beverage Total Events | $4,793 | FoodAndBeverageTotalEventsAmt |
| Oth Direct Expnss Total Events | $27,690 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $84,483 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | -$14,283 | NetIncomeSummaryAmt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (98 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Non Cash AssistanceNonCashAssistanceAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|---|
| BETH ISRAEL DEACONESS MEDICAL CENTER | ||||||||
| 330 BROOKLINE AVENUE | BOSTON | MA | 02215 | 042103881 | 501 (C)(3) | $118,450 | $0 | AGP: GENOMIC VARIANT CALLING AND DATA MANAGEMENT FOR THE CURE ALZHEIMER'S FUND ALZHEIMER'S GENOME PROJECT |
| BOSTON CHILDREN'S HOSPITAL | ||||||||
| 300 LONGWOOD AVE | BOSTON | MA | 02115 | 042774441 | 501 (C)(3) | $344,085 | $0 | NIC: EFFECTS OF PERIPHERAL INFLAMMATION ON MYELOID CELL FUNCTION IN ALZHEIMER'S DISEASE |
| BOSTON CHILDREN'S HOSPITAL | ||||||||
| 300 LONGWOOD AVE | BOSTON | MA | 02115 | 042774441 | 501 (C)(3) | $189,750 | $0 | NEUROINFLAMMATION AT THE CHOROID PLEXUS IN ALZHEIMER'S DISEASE |
| BOSTON UNIVERSITY | ||||||||
| 881 COMMONWEALTH AVE | BOSTON | MA | 02215 | 042103547 | 501 (C)(3) | $287,500 | $0 | APOE CONSORTIUM: MODULATION OF SELECTIVE NEURONAL VULNERABILITY IN ALZHEIMER'S DISEASE BY APOE |
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | 042312909 | 501 (C)(3) | $287,500 | $0 | APOE CONSORTIUM: APOE4-MEDIATED DYSFUNCTION OF CD8 T CELL-MICROGLIA CROSSTALK IN ALZHEIMER'S DISEASE |
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | 042312909 | 501 (C)(3) | $287,500 | $0 | MBC: HARNESSING DIET-MICROBE INTERACTIONS TO PREVENT ALZHEIMER'S DISEASE PATHOGENESIS |
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | 042312909 | 501 (C)(3) | $201,250 | $0 | TARGETING NEUROINFLAMMATION WITH NASAL ADMINISTRATION OF ANTI-CD3 MONOCLONAL ANTIBODY TO TREAT ALZHEIMER'S DISEASE |
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | 042312909 | 501 (C)(3) | $201,250 | $0 | ROLE OF CHECKPOINT MOLECULES TIM-3 AND LAG-3 IN MICROGLIAL FUNCTION IN ALZHEIMER'S DISEASE |
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | 042312909 | 501 (C)(3) | $431,250 | $0 | A NEW MODEL OF MICROGLIA GENETIC PERTURBATION IN VIVO TO SCREEN ALL RISK FACTORS ASSOCIATED WITH ALZHEIMER'S DISEASE |
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02111 | 042312909 | 501 (C)(3) | $201,250 | $0 | NEUROIMMUNE CONNECTOME PERTURBATIONS IN ALZHEIMER'S DISEASE |
| BRIGHAM AND WOMEN'S HOSPITAL | ||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | 042312909 | 501 (C)(3) | $201,250 | $0 | TARGETING THE MICROBIOME AND INNATE IMMUNITY IN ALZHEIMER'S DISEASE |
| BROAD INSTITUTE | ||||||||
| 415 MAIN STREET | CAMBRIDGE | MA | 02142 | 263428781 | 501 (C)(3) | $172,550 | $0 | REVEALING NEW GENES AND PATHWAYS AT THE INTERSECTION OF LIPOTOXIC AND GENETIC RISK FOR ALZHEIMER'S DISEASE |
| COLUMBIA UNIVERSITY | ||||||||
| 630 WEST 168TH STREET BOX 49 | NEW YORK | NY | 10032 | 135598093 | 501 (C)(3) | $201,250 | $0 | NONCODING TRANSLATION FEEDBACK LOOP IN ALZHEIMER'S DISEASE |
| COLUMBIA UNIVERSITY | ||||||||
| 630 WEST 168TH STREET BOX 49 | NEW YORK | NY | 10032 | 135598093 | 501 (C)(3) | $201,501 | $0 | NEUROPROTEASOMES MECHANISTICALLY CONNECT APOE ISOFORMS TO ENDOGENOUS TAU AGGREGATION |
| DUKE UNIVERSITY SCHOOL OF MEDICINE | ||||||||
| 324 BLACKWELL STREET SUITE 900 | DURHAM | NC | 27701 | 560532129 | 501 (C)(3) | $229,994 | $0 | UTILITY OF BLOOD BASED MARKERS FOR PREDICTING ARIA AND ITS COURSE IN MCI AND AD SUBJECTS UNDERGOING ROUTINE CLINICAL TREATMENT WITH AMYLOID-DIRECTED ANTIBODIES |
| DUKE UNIVERSITY SCHOOL OF MEDICINE | ||||||||
| 324 BLACKWELL STREET SUITE 900 | DURHAM | NC | 27701 | 560532129 | 501 (C)(3) | $195,434 | $0 | CONTRIBUTIONS OF IL34 SIGNALING TO MICROGLIAL FUNCTION AND ALZHEIMER'S PATHOLOGY IN MICE |
| EMORY UNIVERSITY | ||||||||
| 1599 CLIFTON ROAD NE 4TH FLOOR | ATLANTA | GA | 30322 | 580566256 | 501 (C)(3) | $201,250 | $0 | MITOCHONDRIAL ALZHEIMER'S RISK FACTORS CONTROL APOE EXPRESSION AND SECRETION |
| HARVARD MEDICAL SCHOOL | ||||||||
| 1033 MASSACHUSETTS VE 3RD FLOOR | BOSTON | MA | 02138 | 042103580 | 501 (C)(3) | $40,250 | $0 | GENETIC ANCESTRY-SPECIFIC RISK ESTIMATION OF ALZHEIMER'S DISEASE (AD) IN THE APOE REGION |
| HARVARD MEDICAL SCHOOL | ||||||||
| 1033 MASSACHUSETTS VE 3RD FLOOR | CAMBRIDGE | MA | 02138 | 042103580 | 501 (C)(3) | $150,000 | $0 | PRECISION MEDICINE PREDICTION MODEL FOR ALZHEIMER'S DISEASE USING COOPERATIVE LEARNING APPROACHES FOR MULTI-OMIC DATA |
| HARVARD MEDICAL SCHOOL | ||||||||
| 1033 MASSACHUSETTS VE 3RD FLOOR | CAMBRIDGE | MA | 02138 | 042103580 | 501 (C)(3) | $220,071 | $0 | ANALYTICAL AND STATISTICAL TOOLS FOR SEQUENCE ANALYSIS FOR ALZHEIMER'S DISEASE |
| ICAHN SCOOL OF MEDICINE AT MOUNT SINAI | ||||||||
| ONE GUSTAVE L LEVY PLACE BOX 1075 | NEW YORK | NY | 10029 | 136171197 | 501 (C)(3) | $172,500 | $0 | IN VIVO MODELS FOR GOLGI FRAGMENTATION AND THE MOLECULAR PATHOGENESIS OF ALZHEIMER'S DISEASE |
| ICAHN SCOOL OF MEDICINE AT MOUNT SINAI | ||||||||
| ONE GUSTAVE L LEVY PLACE BOX 1075 | NEW YORK | NY | 10029 | 136171197 | 501 (C)(3) | $172,500 | $0 | STRESS AND NEUROVASCULAR-IMMUNE NETWORKS IN ALZHEIMER'S DISEASE |
| ICAHN SCOOL OF MEDICINE AT MOUNT SINAI | ||||||||
| ONE GUSTAVE L LEVY PLACE BOX 1075 | NEW YORK | NY | 10029 | 136171197 | 501 (C)(3) | $201,250 | $0 | INVESTIGATING MEF2C TRANSCRIPTION FACTOR AS THERAPEUTIC TARGET TO REPROGRAM PATHOLOGICAL MICROGLIAL STATES IN ALZHEIMER'S DISEASE |
| ICAHN SCOOL OF MEDICINE AT MOUNT SINAI | ||||||||
| ONE GUSTAVE L LEVY PLACE BOX 1075 | NEW YORK | NY | 10029 | 136171197 | 501 (C)(3) | $172,500 | $0 | INVESTIGATING BONE MARROW HEMATOPOIESIS AND THE LINK BETWEEN SLEEP FRAGMENTATION AND VASCULAR INFLAMMATION IN AD |
| ICAHN SCOOL OF MEDICINE AT MOUNT SINAI | ||||||||
| ONE GUSTAVE L LEVY PLACE BOX 1075 | NEW YORK | NY | 10029 | 136171197 | 501 (C)(3) | $201,250 | $0 | INVESTIGATING LYSOSOMAL MECHANISMS OF RISK AND RESILIENCE IN ALZHEIMER'S DISEASE |
| JOHNS HOPKINS UNIVERSITY | ||||||||
| 733 N BROADWAY MRB SUITE 117 | BALTIMORE | MD | 21205 | 520595110 | 501 (C)(3) | $201,250 | $0 | HUMAN BRAIN CD33 LIGAND, RPTPS3L, LIMITS MICROGLIAL PHAGOCYTOSIS AND CONTRIBUTES TO ALZHEIMER'S DISEASE PROGRESSION |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA ST SUITE 540 | BOSTON | MA | 02114 | 041564655 | 501 (C)(3) | $1,955,000 | $0 | THE CUREALZ ALZHEIMER'S GENOME PROJECT |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA ST SUITE 540 | BOSTON | MA | 02114 | 041564655 | 501 (C)(3) | $172,500 | $0 | TAU AND -AMYLOID ARE INNATE IMMUNE ANTIMICROBIAL PEPTIDES IN THE BRAIN |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA ST SUITE 540 | BOSTON | MA | 02114 | 041564655 | 501 (C)(3) | $172,000 | $0 | REGIONAL VARIABILITY OF PATHOLOGY-ASSOCIATED PROPERTIES OF TAU IN POSTERIOR CORTICAL ATROPHY |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA ST SUITE 540 | BOSTON | MA | 02114 | 041564655 | 501 (C)(3) | $201,250 | $0 | ROLE OF STABILIZATION OF MAMS AND MAM-ASSOCIATED PALMITOYLATED APP (MAM-PALAPP) IN ALZHEIMER'S DISEASE |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA ST SUITE 540 | BOSTON | MA | 02114 | 041564655 | 501 (C)(3) | $230,000 | $0 | BEE: A 3D IN-VITRO NEURO-VASCULAR HUMAN BRAIN MODEL WITH MENINGEAL LYMPHATICS FOR ELUCIDATING MECHANISMS UNDERLYING ALZHEIMER'S DISEASE |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA ST SUITE 540 | BOSTON | MA | 02114 | 041564655 | 501 (C)(3) | $201,250 | $0 | ROLE OF RIN3 AND BIN1 INTERACTION IN THE NEURONS FOR ALZHEIMER'S DISEASE DEVELOPMENT |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA ST SUITE 540 | BOSTON | MA | 02114 | 041564655 | 501 (C)(3) | $201,250 | $0 | CHARACTERIZING GUT BACTERIOME-MYCOBIOME SYNERGY IN CORRELATION TO AMYLIN-A ANTIMICROBIAL SYNERGY IN ALZHEIMER'S DISEASE (AD) IN AD MOUSE MODELS |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA ST SUITE 540 | BOSTON | MA | 02114 | 041564655 | 501 (C)(3) | $287,169 | $0 | ADTC: HOW DO SOLUBLE TAU SPECIES REPLICATE? |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA ST SUITE 540 | BOSTON | MA | 02114 | 041564655 | 501 (C)(3) | $125,000 | $0 | THE IMPACT OF MUTATIONS IN THE LIGAND-BINDING DOMAIN OF CD33 ON ALZHEIMER'S DISEASE PATHOGENESIS |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA ST SUITE 540 | BOSTON | MA | 02114 | 041564655 | 501 (C)(3) | $201,250 | $0 | ROLE OF CD8+ T CELL-GLIAL INTERACTIONS IN MEDIATING ALZHEIMER'S DISEASE PATHOGENESIS |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA ST SUITE 540 | BOSTON | MA | 02114 | 041564655 | 501 (C)(3) | $300,000 | $0 | UNDERSTANDING HUMAN BRAIN RESILIENCE TO ALZHEIMER'S PATHOLOGY |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA ST SUITE 540 | BOSTON | MA | 02114 | 041564655 | 501 (C)(3) | $345,000 | $0 | NEUROPROTECTIVE EFFECTS OF THE EXERCISE HORMONE IRISIN IN ALZHEIMER'S DISEASE |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA ST SUITE 540 | BOSTON | MA | 02114 | 041564655 | 501 (C)(3) | $201,250 | $0 | VALIDATION AND CHARACTERIZATION OF COMPOUNDS MODULATING NEUROINFLAMMATION AND AMYLOID BETA UPTAKE IN MICROGLIAL CELLS |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA ST SUITE 540 | BOSTON | MA | 02114 | 041564655 | 501 (C)(3) | $258,750 | $0 | FUNCTIONAL CHANGES TO CEREBROSPINAL FLUID IMMUNE CELLS RESULTING FROM BACILLUS CALMETTE-GURIN (BCG) VACCINATION IN OLDER ADULTS WITH AND WITHOUT ALZHEIMER'S DISEASE |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA ST SUITE 540 | BOSTON | MA | 02114 | 041564655 | 501 (C)(3) | $201,250 | $0 | CHARACTERIZATION OF CNS-PENETRANT HDAC11-SELECTIVE INHIBITORS IN ALZHEIMER'S DISEASE MODELS |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA ST SUITE 540 | BOSTON | MA | 02114 | 041564655 | 501 (C)(3) | $95,594 | $0 | GENERAL SCIENTIFIC SUPPORT |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA ST SUITE 540 | BOSTON | MA | 02114 | 041564655 | 501 (C)(3) | $201,250 | $0 | GROWTH, CHARACTERIZATION, AND DISTRIBUTION OF A NEURODEGENERATIVE DISEASE-FOCUSED FIBROBLAST/IPS CELL BANK TO SUPPORT MOLECULAR MODELS OF PATIENT-SPECIFIC VARIATION WITH VALIDATION IN MATCHED DONATED BRAIN TISSUES |
| MASSACHUSETTS GENERAL HOSPITAL | ||||||||
| 125 NASHUA ST SUITE 540 | BOSTON | MA | 02114 | 041564655 | 501 (C)(3) | $287,500 | $0 | MBC: MICROBIAL PROFILING OF HUMAN BRAIN AND GUT MICROBIOMES IN ALZHEIMER'S DISEASE |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | ||||||||
| 77 MASSACHUSETTS AVENUE | CAMBRIDGE | MA | 02139 | 042103594 | 501 (C)(3) | $300,000 | $0 | CIRCUITS: DISSECTING MICROGLIAL STATE DYNAMICS IN ALZHEIMER'S DISEASE |
| MAYO CLINIC JACKSONVILLE | ||||||||
| 4500 SAN PABLO ROAD | JACKSONVILLE | FL | 32224 | 593337028 | 501 (C)(3) | $201,250 | $0 | RESTORE MENINGEAL LYMPHATIC DRAINAGE TO ALLEVIATE WHITE MATTER DAMAGE AND CEREBRAL AMYLOID ANGIOPATHY IN A MODEL OF ALZHEIMER'S DISEASE |
| MAYO CLINIC JACKSONVILLE | ||||||||
| 4500 SAN PABLO ROAD | JACKSONVILLE | FL | 32224 | 593337028 | 501 (C)(3) | $201,250 | $0 | ABCA7 LOSS OF FUNCTION IN AGING AND ALZHEIMER'S DISEASE |
| MAYO CLINIC JACKSONVILLE | ||||||||
| 4500 SAN PABLO ROAD | JACKSONVILLE | FL | 32224 | 593337028 | 501 (C)(3) | $172,500 | $0 | TARGETING MICROGLIAL TSG 101 FOR SYNAPTIC PROTECTION AND COGNITIVE ENHANCEMENT IN ALZHEIMER'S DISEASE |
| MAYO CLINIC JACKSONVILLE | ||||||||
| 4500 SAN PABLO ROAD | JACKSONVILLE | FL | 32224 | 593337028 | 501 (C)(3) | $201,250 | $0 | EVALUATING TMEM106B ACCUMULATION IN AD |
| MAYO CLINIC JACKSONVILLE | ||||||||
| 4500 SAN PABLO ROAD | JACKSONVILLE | FL | 32224 | 593337028 | 501 (C)(3) | $201,250 | $0 | ELUCIDATING THE PROTECTIVE EFFECTS OF APOE2 IN THE PRESENCE OF APOE4 GENE ALLELE IN ANIMAL MODELS |
| MEMORIAL SLOAN KETTERING CANCER CENTER | ||||||||
| 1275 YORK AVE | NEW YORK | NY | 10065 | 131924236 | 501 (C)(3) | $230,000 | $0 | THE ROLE OF IFITM3 AND Y-SECRETASE IN MICROGLIA |
| NEW YORK UNIVERSITY | ||||||||
| 550 FIRST AVE | NEW YORK | NY | 10016 | 135562308 | 501 (C)(3) | $208,033 | $0 | MECHANISMS OF ASTROCYTE-DERIVED LIPID TOXICITY IN ALZHEIMER'S DISEASE |
| NORTHWESTERN UNIVERSITY | ||||||||
| 710 N LAKE SHORE DRIVE | CHICAGO | IL | 60611 | 362167817 | 501 (C)(3) | $172,500 | $0 | T CELL EPIGENETICS IN ALZHEIMER'S DISEASE |
| NORTHWESTERN UNIVERSITY | ||||||||
| 710 N LAKE SHORE DRIVE | CHICAGO | IL | 60611 | 362167817 | 501 (C)(3) | $345,000 | $0 | MBC: INTERACTION OF THE MICROBIOME WITH ASTROCYTES AND AMYLOID PATHOLOGY |
| NORTHWESTERN UNIVERSITY | ||||||||
| 710 N LAKE SHORE DRIVE | CHICAGO | IL | 60611 | 362167817 | 501 (C)(3) | $286,448 | $0 | ADTC: THE ROLE OF A-INDUCED MEMBRANE DAMAGE IN TAU PATHOLOGY |
| NORTHWESTERN UNIVERSITY | ||||||||
| 710 N LAKE SHORE DRIVE | CHICAGO | IL | 60611 | 362167817 | 501 (C)(3) | $136,827 | $0 | INTERROGATING LEVETIRACETAM'S IMPACT ON AMYLOID PATHOLOGY AND PRESYNAPTIC PROTEOSTASIS IN KNOCK-IN MOUSE MODELS WITH HUMANIZED ABETA |
| STANFORD UNIVERSITY | ||||||||
| 485 BROADWAY | REDWOOD CITY | CA | 94063 | 941156365 | 501 (C)(3) | $201,250 | $0 | MULTIOMICS CHARACTERIZATION OF TAU PATHOLOGY ONSET AND ITS RELATIONSHIP WITH AMYLOID IN THE HUMAN HIPPOCAMPUS |
| STANFORD UNIVERSITY | ||||||||
| 485 BROADWAY | REDWOOD CITY | CA | 94063 | 941156365 | 501 (C)(3) | $198,751 | $0 | OLIGODENDROGLIAL DYNAMICS AND MYELINATION IN ALZHEIMER'S DISEASE |
| THE METHODIST HOSPITAL FOUNDATION | ||||||||
| PO BOX 4384 | HOUSTON | TX | 77210 | 760094743 | 501 (C)(3) | $201,199 | $0 | A MUTI-MODALITY STUDY ON LIPID MOLECULAR BASIS OF OBESITY AND ITS ROLES IN REGULATING ALZHEIMER'S PATHOGENESIS FOR DEVELOPING POTENTIAL TARGETED INTERVENTIONS |
| THE REGENTS OF THE UNIVERSITY OF CALIFORMIA SAN FRANCISCO | ||||||||
| 490 ILLINOIS STREET 4TH FLOOR | SAN FRANCISCO | CA | 94143 | 943067788 | 501 (C)(3) | $201,250 | $0 | NEURONAL MECHANISMS DRIVING SYNAPSE LOSS IN ALZHEIMER'S DISEASE |
| THE SALK INSTITUTE FOR BIOLOGIAL STUDIES | ||||||||
| 10010 NORTH TORREY PINES ROAD | LA JOLLA | CA | 92037 | 952160097 | 501 (C)(3) | $201,250 | $0 | TO ELUCIDATE THE ROLE OF MEMORY T CELLS AS A DETERMINANT OF AGE-RELATED INFLAMMATION IN ALZHEIMER'S DISEASE |
| THE SALK INSTITUTE FOR BIOLOGIAL STUDIES | ||||||||
| 10010 NORTH TORREY PINES ROAD | LA JOLLA | CA | 92037 | 952160097 | 501 (C)(3) | $172,500 | $0 | THE ROLE OF ASTROCYTE-SECRETED IGFBP2 IN THE PROGRESSION OF ALZHEIMER'S DISEASE |
| TUFTS UNIVERSITY | ||||||||
| 136 HARRISON AVENUE | BOSTON | MA | 02111 | 042103634 | 501 (C)(3) | $201,250 | $0 | MULTIDISCIPLINARY PHENOTYPING OF A NOVEL HUMANIZED LOAD MOUSE MODEL |
| UNIVERSITY OF CALIFORNIA IRVINE | ||||||||
| 120 THEORY SUITE 200 | IRVINE | CA | 92697 | 952226406 | 501 (C)(3) | $287,493 | $0 | NIC: EXAMINING THE IMPACT OF PERIPHERALLY DERIVED HUMAN MACROPHAGES IN AD PATHOGENESIS |
| UNIVERSITY OF CALIFORNIA IRVINE | ||||||||
| 120 THEORY SUITE 200 | IRVINE | CA | 92697 | 952226406 | 501 (C)(3) | $230,000 | $0 | ENDOGENOUS HUMAN ANTIBODIES ASSOCIATED WITH ALZHEIMER'S DISEASE |
| UNIVERSITY OF CALIFORNIA SAN DIEGO | ||||||||
| 9500 GILMAN DRIVE MC 0721 | LA JOLLA | CA | 92093 | 952872494 | 501 (C)(3) | $287,500 | $0 | NIC: MECHANISMS MEDIATING MICROGLIA SENSING OF PERIPHERAL INFLAMMATION |
| UNIVERSITY OF CALIFORNIA SAN DIEGO | ||||||||
| 9500 GILMAN DRIVE BSB3092 | LA JOLLA | CA | 92093 | 952872494 | 501 (C)(3) | $230,000 | $0 | APP GENE DOSE-MEDIATED DYSREGULATION OF THE ENDOLYSOSOMAL NETWORK ACTS COMPROMISE SYNAPTIC STRUCTURE AND FUNCTION LEADING TO ALZHEIMER'S DISEASE IN DOWN SYNDROME |
| UNIVERSITY OF CALIFORNIA SAN DIEGO | ||||||||
| 9500 GILMAN DRIVE DEPT 0651 | LA JOLLA | CA | 92093 | 952872494 | 501 (C)(3) | $287,500 | $0 | BEE: IDENTIFYING THE BLOOD-BRAIN BARRIER CHANGES DURING ALZHEIMER'S DISEASE |
| UNIVERSITY OF CHICAGO | ||||||||
| 5801 SOUTH ELLIS AVE | CHICAGO | IL | 60637 | 362177139 | 501 (C)(3) | $250,000 | $0 | MBC: TEMPORAL RELATIONSHIPS BETWEEN GUT DYSBIOSIS, BRAIN AB METABOLISM AND MICROGLIA CELL ACTIVATION FOLLOWING ANTIBIOTIC TREATMENT |
| UNIVERSITY OF CONNECTICUT | ||||||||
| 263 FARMINGTON AVE | FARMINGTON | CT | 06053 | 060772160 | 501 (C)(3) | $230,000 | $0 | AD PATHOPHYSIOLOGY ALTERS THE LEVEL OF ELECTRICAL AND CHEMICAL SYNAPSE COUPLING IN THE NETWORK OF GABAERGIC PV+ INTERNEURONS EARLY IN DISEASE COURSE |
| UNIVERSITY OF MICHIGAN | ||||||||
| 3003 SOUTH STATE STREET | ANN ARBOR | MI | 48109 | 386006309 | 501 (C)(3) | $201,250 | $0 | MORPHOLOGICAL, ELECTROPHYSIOLOGICAL, AND TRANSCRIPTIONAL CHARACTERIZATION OF SINGLE NEURONS FROM RESILIENT AND SUSCEPTIBLE MODELS OF HUMAN AD |
| UNIVERSITY OF MICHIGAN | ||||||||
| 3003 SOUTH STATE STREET | ANN ARBOR | MI | 48109 | 386006309 | 501 (C)(3) | $57,500 | $0 | IN VIVO MODELS FOR GOLGI FRAGMENTATION AND THE MOLECULAR PATHOGENESIS OF ALZHEIMER'S DISEASE |
| UNIVERSITY OF RHODE ISLAND | ||||||||
| 75 LOWER COLLEGE ROAD | KINGSTON | RI | 02881 | 223011455 | 501 (C)(3) | $201,250 | $0 | EFFECT OF APOE GENOTYPE IN A NOVEL RAT MODEL OF CEREBRAL AMYLOID ANGIOPATHY |
| UNIVERSITY OF SOUTHERN CALIFORNIA | ||||||||
| 3500 S FIGUEROA STREET SUITE 102 | LOS ANGELES | CA | 90089 | 951642394 | 501 (C)(3) | $201,250 | $0 | PRENATAL INFLAMMATION EFFECTS ON BLOOD BRAIN BARRIER FUNCTION AND AD-RELATED PATHOLOGIES ACROSS THE LIFESPAN |
| UNIVERSITY OF SOUTHERN CALIFORNIA | ||||||||
| 3500 S FIGUEROA STREET SUITE 102 | LOS ANGELES | CA | 90089 | 951642394 | 501 (C)(3) | $301,069 | $0 | AIR POLLUTION AND AD RISK INTERACT WITH PREMATURE AGING OF NEURAL STEM CELLS AND APOE ALLELES |
| UNIVERSITY OF SOUTHERN CALIFORNIA | ||||||||
| 3500 S FIGUEROA STREET SUITE 102 | LOS ANGELES | CA | 90089 | 951642394 | 501 (C)(3) | $234,709 | $0 | PROTECTION AGAINST APOE4 WITH LONGEVITY-PROMOTING INTERVENTIONS |
| UNIVERSITY OF SOUTHERN CALIFORNIA | ||||||||
| 3500 S FIGUEROA STREET SUITE 102 | LOS ANGELES | CA | 90089 | 951642394 | 501 (C)(3) | $250,000 | $0 | CELLULAR AND MOLECULAR STUDIES OF APOE REGULATION OF BLOOD-BRAIN BARRIER, SYNAPTIC AND NEURONAL FUNCTIONS AND PROTECTION STRATEGIES IN MOUSE MODELS WITH AND WITHOUT ALZHEIMER'S PAHTOLOGY |
| UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | ||||||||
| 7703 FLOYD CURL DRIVE | SAN ANTONIO | TX | 78229 | 741586031 | 501 (C)(3) | $201,250 | $0 | IDENTIFICATION AND VALIDATION OF PLASMA-BASED LIPID BIOMARKERS FOR EARLY ALZHEIMER'S DISEASE IN THE UNIQUE, PRIMARILY HISPANIC, SOUTH TEXAS POPULATION |
| UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | ||||||||
| 5323 HARRY HINES BLVD | DALLAS | TX | 75390 | 752556007 | 501 (C)(3) | $287,000 | $0 | ADTC: ROLE OF VCP/P97 IN TAU PRION REPLICATION |
| UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | ||||||||
| 5323 HARRY HINES BLVD | DALLAS | TX | 75390 | 752556007 | 501 (C)(3) | $230,000 | $0 | RNA AS A DETERMINANT OF TAU SEEDING |
| UNIVERSITY OF VIRGINIA | ||||||||
| 1001 N EMMETT ST | CHARLOTTESVILLE | VA | 22904 | 546001796 | 501 (C)(3) | $192,020 | $0 | TOXIC EFFECTS OF EXTRACELLULAR TAU OLIGOMERS ON NEURONS |
| UNIVERSITY OF VIRGINIA | ||||||||
| 1001 N EMMETT ST | CHARLOTTESVILLE | VA | 22904 | 546001796 | 501 (C)(3) | $201,250 | $0 | ELUCIDATING THE ROLE OF CLEC7A IN TAU-MEDIATED NEURODEGENERATIVE DISEASE |
| UNIVERSITY OF VIRGINIA | ||||||||
| 1001 N EMMETT ST | CHARLOTTESVILLE | VA | 22904 | 546001796 | 501 (C)(3) | $201,250 | $0 | EXPLORING THE THERAPEUTIC POTENTIAL OF CLUSTERIN IN A PRECLINICAL MODEL OF ALZHEIMER'S DISEASE |
| WASHINGTON UNIVERSITY | ||||||||
| 1 BROOKINGS DRIVE | ST LOUIS | MO | 63130 | 430653611 | 501 (C)(3) | $113,655 | $0 | CHARACTERIZATION OF MOLECULAR BIOMARKER PROFILES THROUGHOUT THE PATHOBIOLOGICAL CONTINUUM |
| WASHINGTON UNIVERSITY | ||||||||
| 1 BROOKINGS DRIVE | ST LOUIS | MO | 63130 | 430653611 | 501 (C)(3) | $287,500 | $0 | MBC: THE ROLE OF GUT MICROBIAL METABOLISM IN TAU-MEDIATED NEURODEGENERATION |
| WASHINGTON UNIVERSITY | ||||||||
| 1 BROOKINGS DRIVE | ST LOUIS | MO | 63130 | 430653611 | 501 (C)(3) | $172,500 | $0 | UNDERSTANDING THE ROLE OF NATURAL A-SPECIFIC B CELL RESPONSES IN AD PROGRESSION |
| WASHINGTON UNIVERSITY | ||||||||
| 1 BROOKINGS DRIVE | ST LOUIS | MO | 63130 | 430653611 | 501 (C)(3) | $189,902 | $0 | DECIPHERING AND RESTORING COMPUTATIONAL SET-POINTS IN ALZHEIMER'S DISEASE THROUGH SLEEP-ENHANCED NETWORK HOMEOSTASIS |
| WASHINGTON UNIVERSITY | ||||||||
| 1 BROOKINGS DRIVE | ST LOUIS | MO | 63130 | 430653611 | 501 (C)(3) | $201,250 | $0 | CONTRIBUTION OF SKULL BONE MARROW-DERIVED CELLS TO ALZHEIMER'S DISEASE |
| WASHINGTON UNIVERSITY | ||||||||
| 1 BROOKINGS DRIVE | ST LOUIS | MO | 63130 | 430653611 | 501 (C)(3) | $345,000 | $0 | BEE: CROSSTALK OF CNS BARRIERS AND CLEARANCE ROUTES IN HOMEOSTASIS AND ALZHEIMER'S DISEASE |
| WASHINGTON UNIVERSITY | ||||||||
| 1 BROOKINGS DRIVE | ST LOUIS | MO | 63130 | 430653611 | 501 (C)(3) | $345,000 | $0 | APOE CONSORTIUM: ROLE OF APOE ISOFORMS IN IMMUNE RESPONSES IN A MODEL OF TAUOPATHY |
| WASHINGTON UNIVERSITY | ||||||||
| 1 BROOKINGS DRIVE | ST LOUIS | MO | 63130 | 430653611 | 501 (C)(3) | $201,248 | $0 | ANTIVIRAL T CELLS INFILTRATION TO THE MENINGES AND BRAIN INFLUENCES NEURODEGENERATION IN ALZHEIMER'S DISEASE |
| WASHINGTON UNIVERSITY | ||||||||
| 1 BROOKINGS DRIVE | ST LOUIS | MO | 63130 | 430653611 | 501 (C)(3) | $201,250 | $0 | DISSECTING ALZHEIMER'S DISEASE PHENOTYPES IN DIRECTLY REPROGRAMMED PATIENT-DERIVED NEURONS |
| WASHINGTON UNIVERSITY | ||||||||
| 1 BROOKINGS DRIVE | ST LOUIS | MO | 63130 | 430653611 | 501 (C)(3) | $198,994 | $0 | CIRCADIAN DESYNCHRONY, GLIAL DYSFUNCTION, AND ALZHEIMER'S DISEASE PATHOGENESIS |
| WEILL CORNELL | ||||||||
| 1300 YORK AVENUE | NEW YORK | NY | 10065 | 136094042 | 501 (C)(3) | $201,250 | $0 | IDENTIFICATION AND DEVELOPMENT OF CD33 INHIBITORS AND PRE-RNA SPLICING MODULATORS |
| WEILL CORNELL | ||||||||
| 1300 YORK AVENUE | NEW YORK | NY | 10065 | 136094042 | 501 (C)(3) | $250,000 | $0 | DEVELOPMENT OF HUMAN CGAS INHIBITORS TO TREAT ALZHEIMER'S DISEASE |
| WEILL CORNELL | ||||||||
| 1300 YORK AVENUE | NEW YORK | NY | 10065 | 136094042 | 501 (C)(3) | $201,250 | $0 | TAU-INDUCED POSTSYNAPTIC DYSFUNCTION IN TAUOPATHY MODELS |
| WEILL CORNELL | ||||||||
| 1300 YORK AVENUE | NEW YORK | NY | 10065 | 136094042 | 501 (C)(3) | $287,500 | $0 | BEE: BIOCHEMICAL AND FUNCTIONAL ANALYSIS OF CSF AND LYMPH FOLLOWING CHANGES IN BRAIN FLUID DYNAMICS |
| YALE UNIVERSITY | ||||||||
| PO BOX 208239 | NEW HAVEN | CT | 06520 | 060646973 | 501 (C)(3) | $204,081 | $0 | BEE: CNS FLUID HOMEOSTASIS AND WASTE CLEARANCE IN ALZHEIMER'S DISEASE CHARACTERIZED BY MRI |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 36 | Total501c3OrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE RESEARCH LEADERSHIP GROUP REVIEWS EACH PROJECT FOR FIT WITH THE CUREALZ RESEARCH PORTFOLIO, SCIENTIFIC INTEGRITY, AND VALUE TO THE SEARCH FOR A CURE FOR ALZHEIMER'S DISEASE. ALL FUNDED RESEARCHERS MAY BE ASKED TO REVIEW OCCASIONAL PROPOSALS ON A TWO-WEEK TIMELINE AS A CONDITION OF RECEIVING FUNDING. THE RESEARCH COMMITTEE OF THE BOARD OF DIRECTORS PROVIDES A FINAL REVIEW TO ENSURE ALL PROCEDURES HAVE BEEN FOLLOWED AND THAT THE PROJECT SERVES THE ORGANIZATION'S MISSION TO FUND RESEARCH ACCELERATING BENEFITS TO CURRENT AND POTENTIAL ALZHEIMER'S PATIENTS. AT LEAST TWO SCIENTIFIC REVIEWERS MUST SUBMIT A POSITIVE REVIEW FOR A PROPOSAL TO BE ACCEPTED. ANY QUESTIONS OR CONCERNS ABOUT THE PROPOSAL BY ANY REVIEWER MAY RESULT IN A REQUEST FOR ITERATION OR REJECTION OF THE PROPOSAL. RESEARCHERS WILL BE ADVISED OF ACCEPTANCE, QUESTIONS, OR REJECTION BUT WILL NOT RECEIVE ANY "SCORE OR ASSESSMENT COMMENTARY FROM REVIEWERS; HOWEVER, SUGGESTIONS OR IDEAS FROM REVIEWERS ARE SYNTHESIZED AND PROVIDED WITHOUT ATTRIBUTION IF A PROPOSAL IS FUNDED. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (10 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KATHARINE HERMAN | ||||||||||||||
| EVP DEVELOPMENT | $405,657 | $0 | $0 | $0 | $0 | $0 | $9,900 | $0 | $20,415 | $0 | $435,972 | $0 | $0 | $0 |
| TIMOTHY ARMOUR | ||||||||||||||
| FORMER PRESIDENT & CEO (TO 09/23) | $350,862 | $0 | $0 | $0 | $0 | $0 | $9,900 | $0 | $960 | $0 | $361,722 | $0 | $0 | $0 |
| MARGARET SMITH | ||||||||||||||
| CEO (AS OF 10/23) | $321,513 | $0 | $0 | $0 | $0 | $0 | $9,900 | $0 | $18,590 | $0 | $350,003 | $0 | $0 | $0 |
| BARBARA CHAMBERS | ||||||||||||||
| EVP MARKETING & COMM. | $254,908 | $0 | $0 | $0 | $0 | $0 | $8,001 | $0 | $14,739 | $0 | $277,648 | $0 | $0 | $0 |
| LISA RAND | ||||||||||||||
| VP MARKETING & COMM. | $193,830 | $0 | $0 | $0 | $0 | $0 | $6,088 | $0 | $12,189 | $0 | $212,107 | $0 | $0 | $0 |
| JOHN SLATTERY | ||||||||||||||
| SVP MAJOR GIFTS | $190,709 | $0 | $0 | $0 | $0 | $0 | $5,813 | $0 | $900 | $0 | $197,422 | $0 | $0 | $0 |
| MAHUA DASGUPTA | ||||||||||||||
| SR. PHILANTROPIC ADVISOR | $168,942 | $0 | $0 | $0 | $0 | $0 | $5,439 | $0 | $19,725 | $0 | $194,106 | $0 | $0 | $0 |
| DANIEL HARPER | ||||||||||||||
| SENIOR PHILANTHROPIC ADVISOR | $181,380 | $0 | $0 | $0 | $0 | $0 | $5,565 | $0 | $6,395 | $0 | $193,340 | $0 | $0 | $0 |
| KELLY WESTERHOUSE | ||||||||||||||
| VP LEADERSHIP GIVING | $155,421 | $0 | $0 | $0 | $0 | $0 | $4,819 | $0 | $5,537 | $0 | $165,777 | $0 | $0 | $0 |
| JOSEPHINE ANTONELLIS | ||||||||||||||
| CHIEF FINANCIAL OFFICER (AS OF 8/23) | $150,986 | $0 | $0 | $0 | $0 | $0 | $4,537 | $0 | $1,006 | $0 | $156,529 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE J, PART I, LINE 3 | FormAndLineReferenceDesc |
| Explanation | AN EXECUTIVE SEARCH FIRM WAS HIRED TO RECRUIT THE NEW CEO. THEY ALSO PROVIDED AN INDEPENDENT COMPENSATION CONSULTATION. WHEN THE NEW CEO CAME ON BOARD A WRITTEN EMPLOYMENT CONTRACT WAS CREATED. | ExplanationTxt |
Schedule L IRS990ScheduleL
Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp
Name Of Interested NameOfInterested
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PROPER VILLIANS LLC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Relationship Description | A PRINCIPAL OF THE INDEPENDENT CONTRACTOR IS THE SPOUSE OF A KEY EMPLOYEE | RelationshipDescriptionTxt |
| Transaction | $257,856 | TransactionAmt |
| Transaction | CREATIVE AND PRODUCTION SERVICES | TransactionDesc |
| Sharing Of Revenues | 0 | SharingOfRevenuesInd |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 42 | ContributionCnt |
| Noncash Contributions Rpt F990 | $8,382,433 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | SALE PRICE | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form8283 Received | 0 | Form8283ReceivedCnt |
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | 0 | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | Yes (1) | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 32B: | FormAndLineReferenceDesc |
| Explanation | WHEN STOCK IS RECEIVED AS A CONTRIBUTION IT IS SOLD IMMEDIATELY UPON RECEIPT OR SOON THEREAFTER AS IS PRACTICAL THROUGH FIRST REPUBLIC BANK AND BANK OF NEW YORK/MELLON. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (7 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 2 | JEFFREY MORBY (DECEASED 9/2023) AND JACQUELINE MORBY WERE BOTH DIRECTORS AND SPOUSES. |
| FORM 990, PART VI, SECTION A, LINE 4 | THE ORGANIZATION MADE CHANGES TO THE BYLAWS AND ARTICLES OF INCORPORATION TO UPDATE FOR CURRENT LANGUAGE AND BEST PRACTICES. THIS INCLUDED REMOVING LIMITS ON THE TOTAL NUMBER OF DIRECTORS AND MOVING FROM NAMES TO TITLES FOR STAFF POSITIONS. THE ARTICLES OF INCORPORATION WERE UPDATED TO ESTABLISH CUREALZ'S FULL INDEPENDENCE. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM 990 IS PREPARED BY THE EXTERNAL AUDITORS AND REVIEWED BY THE CFO. REVISIONS, CORRECTIONS, ETC. ARE MADE AS NECESSARY. ONCE ALL ARE SATISFIED WITH THE FORM, IT IS FINALIZED AND A COPY IS SENT TO ALL BOARD MEMBERS. |
| FORM 990, PART VI, SECTION B, LINE 12C | EACH YEAR THE ORGANIZATION'S CONFLICT OF INTEREST POLICY IS PROVIDED TO ALL OFFICERS, DIRECTORS AND KEY EMPLOYEES. THESE PEOPLE ARE ASKED TO REVIEW THE POLICY AND SIGN A STATEMENT INDICATING THAT THEY UNDERSTAND THE POLICY AND HAVE REPORTED ALL POTENTIAL CONFLICTS DURING THE PAST YEAR IN ACCORDANCE WITH THE POLICY AND WILL REPORT ALL POTENTIAL CONFLICTS DURING THE COMING YEAR. ALL POTENTIAL CONFLICTS ARE EVALUATED BY THE BOARD TO DETERMINE IF A CONFLICT ACTUALLY EXISTS. IN THOSE INSTANCES WHERE THE POTENTIAL TRANSACTION IS A CONFLICT, THE BOARD EXAMINES THE TRANSACTION AND A VOTE IS TAKEN (WITH THOSE INVOLVED RECUSING THEMSELVES) AS TO WHETHER THE ORGANIZATION WILL ENTER INTO THE TRANSACTION. |
| FORM 990, PART VI, SECTION B, LINE 15 | COMPARABILITY DATA IS SUBMITTED ANNUALLY TO THE EXECUTIVE COMMITTEE FOR COMPENSATION APPROVAL FOR THE CEO AND ALL OTHER EMPLOYEES. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. THE ORGANIZATION'S FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST AND AT THE ORGANIZATION'S WEBSITE. |
| FORM 990, PART XII, LINE 2C | THE ORGANIZATION DID NOT CHANGE EITHER ITS OVERSIGHT PROCESS OR SELECTION PROCESS DURING THE TAX YEAR. |